About Transcription factor Sp8
Transcription factor Sp8 (SP8) is a protein
from Homo sapiens identified by UniProt accession
Q8IXZ3, 490 residues long.
MolForge cross-references it against 0 known binders and
151 disease associations.
Target properties
| Protein name | Transcription factor Sp8 |
| UniProt accession | Q8IXZ3 |
| Gene | SP8 |
| Organism | Homo sapiens |
| Length | 490 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (151)
Diseases linked to this target (Open Targets).
- alcohol consumption measurement · score 0.40
- prostate carcinoma · score 0.37
- cortical surface area measurement · score 0.31
- self reported educational attainment · score 0.29
- alcohol use disorder measurement · score 0.29
- smoking status measurement · score 0.29
- male reproductive organ cancer · score 0.29
- cortical thickness · score 0.25
- diet measurement · score 0.25
- mathematical ability · score 0.24
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8IXZ3-F1 | alphafold | PREDICTED | 47.04 | — |
Amino-acid sequence (490 residues)
MLAATCNKIG SPSPSPSSLS DSSSSFGKGF HPWKRSSSSS SASCNVVGSS LSSFGVSGAS RNGGSSSAAA AAAAAAAAAA ALVSDSFSCG GSPGSSAFSL TSSSAAAAAA AAAAAASSSP FANDYSVFQA PGVSGGSGGG GGGGGGGSSA HSQDGSHQPV FISKVHTSVD GLQGIYPRVG MAHPYESWFK PSHPGLGAAG EVGSAGASSW WDVGAGWIDV QNPNSAAALP GSLHPAAGGL QTSLHSPLGG YNSDYSGLSH SAFSSGASSH LLSPAGQHLM DGFKPVLPGS YPDSAPSPLA GAGGSMLSAG PSAPLGGSPR SSARRYSGRA TCDCPNCQEA ERLGPAGASL RRKGLHSCHI PGCGKVYGKT SHLKAHLRWH TGERPFVCNW LFCGKRFTRS DELQRHLRTH TGEKRFACPV CNKRFMRSDH LSKHVKTHSG GGGGGGSAGS GSGGKKGSDT DSEHSAAGSP PCHSPELLQP PEPGHRNGLE
Explore Transcription factor Sp8 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets